Tabradol
Product Images NDC 43093-101

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tabradol (NDC 43093-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fusion Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine Label (Fusion Tabradol Cyclobenzaprine Label)

Label for Cyclobenzaprine Hydrochloride showing the active ingredient name and its chemical name. The label includes a warning not to use if the safety seal is broken, net contents of 0.25 grams, and notes it is repackaged by Fusion Pharmaceuticals LLC, Camarillo, CA. The label also displays the Fusion Pharmaceuticals logo.*

FDA Label Image

Package Label (Fusion Tabradol Package Label)

Tabradol brand oral suspension kit containing cyclobenzaprine hydrochloride 1 mg/mL, labeled as FusePaq by Fusion Pharmaceuticals LLC. The label shows storage instructions to keep the kit at room temperature between 15-30°C (59-86°F), a barcode, and company address in Camarillo, CA. The packaging indicates it is Rx only for prescription use.*

FDA Label Image

Structured Suspension Vehicle (Fusion Tabradol Page 3)

Tabradol packaging label states it contains a structured suspension vehicle free of sugar, dye, and parabens. The contents include purified water, methyl sulfonyl methane (MSM), glycerin, sorbitol, sodium saccharin, citric acid, potassium sorbate, and sodium benzoate. The net contents are 125 mL (4.2 fl oz). Manufactured for Fusion Pharmaceuticals LLC, Camarillo, CA 93012.*

FDA Label Image

Structured Flavor Vehicle Label (Fusion Tabradol Page 4)

Label for Tabradol oral suspension kit by Fusion Pharmaceuticals LLC. It states the product is a structured flavoring vehicle, sugar-, dye-, and paraben-free, containing purified water, glycerin, cherry flavor, xanthan gum, sodium citrate, citric acid, potassium sorbate, and sodium benzoate. Net contents are 125 mL (4.2 fl oz). Packaging includes the Fusion Pharmaceuticals logo.*

FDA Label Image

Instructions (Fusion Tabradol Page 5)

This image shows a text panel providing preparation instructions and contents for an oral suspension kit containing cyclobenzaprine hydrochloride 1 mg/mL with MSM. It includes details about the kit components, compounding steps for the pharmacist, storage conditions, and manufacturer information from Fusion Pharmaceuticals LLC.*

FDA Label Image

Instructiond (Fusion Tabradol Page 6)

Text panel for Tabradol (cyclobenzaprine hydrochloride 1 mg/mL oral suspension kit) by Fusion Pharmaceuticals LLC. The panel provides a description of the kit contents, including cyclobenzaprine hydrochloride, flavor and suspension vehicles, bottle adaptor, oral syringe, and instructions. It also includes initial instructions for the pharmacist on inspecting kit contents.*

FDA Label Image

Instructions (Fusion Tabradol Page 7)

Text panel titled 'Instructions for the Pharmacist (continued)' for Tabradol, cyclobenzaprine hydrochloride 1 mg/mL oral suspension kit. It includes pharmacist instructions for transferring cyclobenzaprine hydrochloride to the flavor bottle, completing the combining process, and relabeling the final suspension. Also provides storage conditions and stability information for the suspension and its components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.